NCT03689218

Brief Summary

The World Food Programme (WFP) has signed MoU with Planning and Development Department of Balochistan in collaboration with Nutrition Cell and National Programme for Family Planning and Primary Health Care, Balochistan for the prevention of stunting. The project will utilize the window of opportunity (1000 days from conception to 2 years) for addressing stunting in children under-two years. Therefore project will recruit pregnant women during first trimester and newborns who delivered from recruited pregnant women will be followed until the age of 2 years. Children 6-12 months of age will be enrolled and followed until the age of two years. The interventions included nutritional supplements during pregnancy, lactation and for children during 6-24 months of age. The project will be implemented in Lady Health Workers (LHWs) covered areas of districts Pishin and Quetta, Balochistan.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,180

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2018

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 15, 2018

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

September 27, 2018

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 28, 2018

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2020

Completed
Last Updated

July 23, 2021

Status Verified

July 1, 2021

Enrollment Period

2.3 years

First QC Date

September 27, 2018

Last Update Submit

July 19, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Reduction in stunting in children at 24 months of age

    10% reduction in stunting

    32 months

Secondary Outcomes (3)

  • Improvement in anemia during pregnancy

    9 months

  • Improvement in anemia in children

    18 months

  • Reduction in low birth weight

    9 months

Study Arms (2)

Control

NO INTERVENTION

The control arm will receive routine public and private health services available in the area.

Intervention

EXPERIMENTAL

Pregnant women in intervention arm will receive 30 sachets of Maamta (Nutritious Food Supplement) during pregnancy and first six months of lactation. Children 6-24 months of age will receive 30 sachets of Wawamum (Lipid-Based Nutrient Supplement) every month during the study.

Dietary Supplement: Maamta (Nutritious Food Supplement)Dietary Supplement: Wawamum (Lipid-Based Nutrient Supplement)

Interventions

Pregnant women will receive 30 sachets of Maamta during pregnancy and first six months of lactation.

Intervention

Children 6-24 months will receive 30 sachets of Wawamum every month during the study.

Intervention

Eligibility Criteria

Age6 Months - 24 Months
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Pregnant women during 1-3 months of pregnancy
  • Child age between 6-12 month at the time of enrollment
  • Willing to participate in the study and provide informed consent
  • Living in catchment area of LHW

You may not qualify if:

  • More than 4 months of pregnancy
  • More than 12 months of child age
  • Not willing to participate in the study and unable provide informed consent
  • Not living in catchment area of LHW

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

District Pishin & Quetta

Quetta, Balochistan, 87300, Pakistan

Location

Aga Khan University

Karachi, Sindh, 74800, Pakistan

Location

MeSH Terms

Conditions

Growth Disorders

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Sajid B Soofi, FCPS, MBBS

    Aga Khan University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

September 27, 2018

First Posted

September 28, 2018

Study Start

August 15, 2018

Primary Completion

November 30, 2020

Study Completion

November 30, 2020

Last Updated

July 23, 2021

Record last verified: 2021-07

Locations